Education
About Us
Working with TipRanks
Follow Us
Getinge (SE:GETI.B)
:GETI.B
GETI.B Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr164.35 - kr240.20
Previous CloseN/A
Volume458.56K
Average Volume (3M)1.55M
Market Cap
kr49.50B
Enterprise Valuekr57.42B
Total Cash (Recent Filing)kr993.00M
Total Debt (Recent Filing)kr11.69B
Price to Earnings (P/E)30.2
Beta1.07
Next Earnings
Apr 22, 2025EPS Estimate
1.93Next Dividend Ex-Date
Apr 23, 2025Dividend Yield2.38%
Share Statistics
EPS (TTM)6.01
Shares Outstanding254,152,370
10 Day Avg. Volume1,404,386
30 Day Avg. Volume1,553,321
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr232.60Price Target Upside23.59% Upside
Rating ConsensusHold
Number of Analyst Covering5
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.98%
Mutual Funds
0.32% Other Institutional Investors
90.69% Public Companies and
Individual Investors
GETI.B FAQ
What was Getinge’s price range in the past 12 months?
Getinge lowest stock price was kr164.35 and its highest was kr240.20 in the past 12 months.
What is Getinge’s market cap?
Getinge’s market cap is kr49.50B.
When is Getinge’s upcoming earnings report date?
Getinge’s upcoming earnings report date is Apr 22, 2025 which is in 12 days.
How were Getinge’s earnings last quarter?
Getinge released its earnings results on Jan 28, 2025. The company reported kr5.28 earnings per share for the quarter, beating the consensus estimate of kr3.596 by kr1.684.
Is Getinge overvalued?
According to Wall Street analysts Getinge’s price is currently Undervalued.
Does Getinge pay dividends?
Getinge pays a Annually dividend of kr4.599 which represents an annual dividend yield of 2.38%. See more information on Getinge dividends here
What is Getinge’s EPS estimate?
Getinge’s EPS estimate is 1.93.
How many shares outstanding does Getinge have?
Getinge has 254,152,370 shares outstanding.
What happened to Getinge’s price movement after its last earnings report?
Getinge reported an EPS of kr5.28 in its last earnings report, beating expectations of kr3.596. Following the earnings report the stock price went up 11.1%.
Which hedge fund is a major shareholder of Getinge?
Currently, no hedge funds are holding shares in SE:GETI.B
---
Company Description
Getinge
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (55% of revenue), surgical workflows (35%), and life sciences (10%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 40% of sales (U.S. 35% of sales), Asia-Pacific 21%, and Europe, Middle East, and Africa the remaining 39%.
---
GETI.B Stock 12 Month Forecast
Average Price Target
kr232.60
▲(23.59% Upside)
Technical Analysis
Elekta AB
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Sectra AB Class B
―
Sedana Medical AB
―
Best Analysts Covering GETI.B
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
-
a rating ―
Copying David Adlington's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of - per trade.
---